4 European Projects Found
Searched on 125080 European Projects
FINISHED
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Read Project
18
Partners Participants
FINISHED
First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept (HERMIONE-2MAN)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
It is usually assumed that transmembrane receptors are inactive unless bound by their respective ligand. Against this dogma, the CLB proposed that some receptors may also be active in the absence of ligand and in this case trigger cell death. These receptors were called dependence receptors (DR) as their expression at the cell surface leads the cell to be dependent for its survival on ligand avail ...
Read Project
5
Partners Participants
FINISHED
Combined Highly Active Anti-retroviral Microbicides (CHAARM)
Start date: Jan 1, 2010, End date: Jun 30, 2015,
This proposal is for a large scale collaborative project in which we propose both to develop novel microbicides directed against new intracellular targets and to investigate novel combinations of highly active anti-retroviral drugs which may be particularly effective as microbicides. Combinations may enhance efficacy but equally importantly will increase the genetic barrier to the development of r ...
Read Project
34
Partners Participants
FINISHED
EUROpean consortium on NEUTralising antibodies using gp41 (EURONEUT-41)
Start date: Jan 1, 2008, End date: Mar 31, 2014,
There is now an increasingly solid body of scientific evidence which demonstrates that the binding of small molecular weight compounds, peptides and antibodies (Abs) to fusion-intermediate conformations of gp41 leads to an inhibition of HIV cell entry. The principal aim of this project is to exploit this information by establishing a platform where gp41-derived vaccine candidates will be designed ...
Read Project
